Tarek H Mouhieddine

27PUBLICATIONS
177CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Medical molecular engineering of nucleic acids and proteinsCancer geneticsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (27)

|Sep 16, 2026
Current and new approaches to the treatment landscape for adults with Waldenström macroglobulinemia.

|Sep 09, 2026
Treatment Decisions in Multiple Myeloma.

|Apr 08, 2026
Daratumumab in high-risk MGUS and low-risk smoldering myeloma: results of the Phase II D-PRISM study.

Omar Nadeem, Michelle P Aranha, Robert A Redd

|May 03, 2025
Extramedullary disease but not paraskeletal disease portends inferior outcomes after CAR T cell therapy in multiple myeloma.

Darren Pan, Tarek H Mouhieddine, Tianxiang Sheng

|Feb 26, 2025
Impact of Prior Selinexor Exposure on Outcomes of Chimeric Antigen Receptor T-Cell Therapy for Relapsed/Refractory Multiple Myeloma: An Exploratory Analysis.

Bruno Almeida Costa, Danai Dima, Tomer Mark

|Sep 16, 2024
Multiple Myeloma Risk and Outcomes Are Associated with Pathogenic Germline Variants in DNA Repair Genes.

Santiago Thibaud, Ryan L Subaran, Scott Newman

Pageof 5

Frequent Collaborators

8 joint publications

Irene M Ghobrial

7 joint publications

Gad Getz

7 joint publications

Hearn Jay Cho

6 joint publications

Joshua Richter